Proximal Optimization Technique in Unprotected LMCA

Proximal optimization technique (POT) has been recommended as a standard strategy in bifurcation lesions because it facilitates proper stent implantation and apposition in the proximal main vessel, according to the European Bifurcation Club.

POT en el TCI no protegido

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery (LMCA) has specific characteristics, and the long-term impact of this strategy has not been evaluated on follow-up.

Researchers conducted an analysis of 162 patients who underwent unprotected LMCA PCI. Of those, 99 (61.1%) underwent the POT, while 63 completed the procedure without POT.

The primary endpoint was a bifurcation-oriented composite of events (PEP BOCE) that included cardiac death, target-bifurcation infarction (TBI), and target-bifurcation- revascularization (TBR).

The mean age was 75 years, and 75% of subjects were men. Overall, 19% had diabetes, 67% had hypertension and 47% had undergone previous PCI.

Additionally, 89% had acute coronary syndrome, while silent ischemia and stable chronic syndromes were less frequent. Ejection fraction was 48%.

Read also: Post TAVR Long Term Outcomes in Patients with Chronic Inflammatory Disease.

About 39% of the cases were true bifurcations. Femoral access was used in 81% of cases, and the use of intracoronary imaging was low (16% for optical coherence tomography [OCT] and 1% for intravascular ultrasound [IVUS]).

At the 5-year follow-up, the PFP BOCE favored those who underwent the POT (20% vs. 37%, hazard ratio [HR]: 0.42 [0.22-0.80], p=0.009). There was no difference in cardiac mortality, TBI or TBR, as well as in stent thrombosis. The need for any revascularization was greater in those who did not undergo the POT (25% vs. 32%, p=0.008).

In the multivariate analysis, the use of POT was a strong predictor of BOCE, cardiac death, need for any revascularization, and non-cardiac death.

Conclusion

The POT improves evolution. These findings strongly support the routine use of POT in patients undergoing unprotected LMCA PCI.

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL‐LM.

Reference: Corentin Volet MMed, et, al. Catheter Cardiovasc Interv. 2024;103:340–347.      


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...